Showing 881 - 890 of 896 for "Pharmaceutical" with applied filters
04 May 2020 by
Peter Hallett and Lucy Hartland of Spruson & Ferguson provide answers to some questions about the impact of COVID-19 on IP law and practice in Australia
15 April 2020 by
Eduardo Castillo San Martín, Isabel Bandín Barreiro and Jaime Bello Ayala of Gómez Acebo & Pombo report on the measures in Spain, including the impact of the pandemic on IP law and practice, and the legal risks for IP owners and users
13 April 2020 by
Peter Ruess and Tim Smentkowski of Arnold Ruess examine the IP-related measures taken by the German government to mitigate the impact of the COVID-19 pandemic as well as how the German courts are coping
11 November 2019 by
The Peruvian Patent Office has published the new guidelines for obtaining a compulsory license
17 October 2019 by
To celebrate the 10-year anniversary of the UK Supreme Court, Managing IP featured some of the decisions of the court and the pending appeals involving firms such as Allen & Overy, Bristows, EIP Legal, Herbert Smith Freehills, Osborne Clarke and Powell Gilbert
02 October 2019 by
Indran Shanmuganathan, Michelle Loi Choi Yoke, and Yap Khai Jian of Shearn Delamore & Co provide an in-depth analysis of the Federal Court’s decision in Merck Sharp & Dohme & Anor v Hovid Berhad, a patentee-friendly judgment which overturned a previous ruling on the assessment of dependent and independent claims
27 September 2019 by
Adriana Barrera of Barrera & Asociados (BARLAW) summarizes the Peruvian Patent Office’s report on its patent and design adjudication work in the past five years
17 August 2019 by
The firm hired four IP litigators, two of whom are ranked as patent stars, from a rival
30 July 2019 by
Four law firms were involved in the multi-billion dollar merger of Mylan and Upjohn, Pfizer’s off-patent branded and generics business
01 July 2019 by
Some IP firms in Asia-Pacific and Europe announced promotions and appointments today